Principles of Addiction MedicineRichard K. Ries, Shannon C. Miller, David A. Fiellin This respected text from the American Society of Addiction Medicine is valuable for all physicians and mental-health personnel who specialize in addiction medicine and who treat patients with addiction disorders. The chapters blend scientific principles underlying addiction with the practical essentials of clinical addiction medicine. Many of the contributors are affiliated with leading government agencies that study addiction and its science, such as the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse. The book will appeal to a wide and interdisciplinary range of professionals, especially those with interest or duties relating to addiction-related disorders, and in particular physicians seeking certification status via either the American Board of Addiction Medicine or the American Board of Psychiatry and Neurology. A companion Website will offer the fully searchable text. |
Contents
Cardiovascular Consequences | 71 |
as Contrasted with ShortActing | 117 |
The Pharmacology of Cocaine | 133 |
Dobrin BS and David C S Roberts | 159 |
Eric J Nestler MD | 179 |
Thomas R Kosten MD David | 193 |
Karan MD FACP FASAM | 208 |
Domenic A Ciraulo MD and Clifford M Knapp | 231 |
Group Therapies | 899 |
Contingency Management and | 909 |
Approach | 920 |
Network Therapy | 939 |
Liver Disorders Related to Alcohol | 989 |
and Derya Bora Hazar MD | 1009 |
to Alcohol and Other Drug | 1019 |
Respiratory Tract Disorders Related | 1031 |
Balster | 241 |
Androgenic Steroids | 251 |
Diagnosis Assessment | 265 |
SIDEBAR Trauma Centers Hospitals Emergency | 284 |
SIDEBAR Screening for Alcoholism and Other | 293 |
Treatment of Heavy Drinking | 335 |
Effects of Treatment Setting | 379 |
The ASAM Placement Criteria | 387 |
David MeeLee MD | 401 |
The Harm Reduction Approach | 423 |
Quality Improvement | 433 |
Addiction Management | 441 |
Special Issues in Addiction Medicine | 451 |
and Withdrawal | 559 |
Management of SedativeHypnotic | 573 |
Management of Opioid Intoxication | 589 |
Clinical | 631 |
Paul H Earley MD FASAM | 645 |
Opioid Dependence | 651 |
Management of Intoxication | 677 |
423 | 686 |
Andrew J Saxon MD | 689 |
433 | 699 |
Pharmacologic Interventions | 723 |
Aversion Therapies | 843 |
Family Involvement in Addiction | 857 |
Pharmacologic Interventions for Other | 869 |
Jeffery N Wilkins MD Mark Hrymoc | 875 |
743 | 883 |
HIV TB and Other Infectious | 1057 |
Sleep Disorders Related to Alcohol | 1077 |
Traumatic Injuries Related | 1091 |
Endocrine and Reproductive | 1099 |
SubstanceInduced Mental Disorders | 1139 |
Cooccurring Addiction | 1151 |
Angela E Waldrop PhD Karen J Hartwell | 1183 |
Cooccurring Addiction | 1193 |
Cooccurring Addiction and Attention | 1211 |
Linda A Dimeff PhD Katherine Anne Comtois PhD | 1227 |
Integrating Psychosocial Services | 1239 |
Posttraumatic Stress Disorder | 1249 |
Cooccurring Addiction | 1263 |
Pain and Addiction | 1275 |
Psychological Issues in | 1297 |
Nonopioid Treatments | 1317 |
Adolescent Cigarette Smoking | 1411 |
Screening and Brief Intervention | 1421 |
Assessing Adolescent Substance Use | 1429 |
Adolescent Treatment | 1445 |
SIDEBAR Confidentiality in Dealing with | 1465 |
Cooccurring Psychiatric | 1473 |
Issues in Addiction Practice 1483 and The Hon William G Schma Ret | 1485 |
Parran Jr MD FACP Appendix 4 Summary of the | 1495 |
SIDEBAR Workplace Drug Testing and the Role Index | 1508 |
| 1528 | |
| 1535 | |